Komori
Governance4582SymBio Pharmaceuticals LimitedPharmaceuticals

Corporate Governance Report 2026/08/05

The company operates as a company with an Audit and Supervisory Committee, with a Nomination and Compensation Committee, Internal Control Committee, and Compliance Committee established under the Board of Directors. There are 4 directors excluding Audit and Supervisory Committee members and 3 Audit and Supervisory Committee members, for a total of 6 outside directors.

Worth reading
85Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of directors7 directors in total, including 6 outside directors: 3 of the 4 directors excluding Audit and Supervisory Committee members, and all 3 Audit and Supervisory Committee members, are outside directors.
Committee3
Nomination and Compensation CommitteeInternal Control CommitteeCompliance Committee
Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of directors7 directors in total, including 6 outside directors: 3 of the 4 directors excluding Audit and Supervisory Committee members, and all 3 Audit and Supervisory Committee members, are outside directors.
CommitteeNomination and Compensation Committee (proportion of outside members: Not disclosed), Internal Control Committee (proportion of outside members: Not disclosed), Compliance Committee (proportion of outside members: Not disclosed)
Items this document does not state (5)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholderChanges this time

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The report does not state the reasons for establishing the committees or other bodies.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Corporate Governance Report 2026/08/05 | SymBio Pharmaceuticals Limited (4582) timely disclosure | Komori